SITE009-0259

SITE009 (AUS) › SITE009-0259

SITE009-0259

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE009 (AUS) · Dr. Novak
consented 2026-07-09

completed

AEs

7

Serious

0

Dropout signal

–

Adverse events

7

Grade 1 Anaemia — outcome: RECOVERED/RESOLVED; onset 2023-02-26 (study day 49); relationship: NOT RELATED

mild assessed

Grade 1 Nausea — outcome: RECOVERED/RESOLVED; onset 2023-02-11 (study day 34); relationship: not assessed

mild assessed

Grade 1 Dyspnoea — outcome: RECOVERED/RESOLVED; onset 2023-02-05 (study day 28); relationship: not assessed

mild assessed

Grade 2 Thrombocytopenia — outcome: RECOVERED/RESOLVED; onset 2023-02-02 (study day 25); relationship: not assessed

moderate assessed

Grade 2 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2023-02-02 (study day 25); relationship: not assessed

moderate assessed

Grade 1 Constipation — outcome: RECOVERED/RESOLVED; onset 2023-01-13 (study day 5); relationship: not assessed

mild assessed

Grade 1 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2023-01-10 (study day 2); relationship: NOT RELATED

mild assessed

Data queries

0

No data queries. Open queries would appear here for this patient.